POMPANO BEACH, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announces it will release its third quarter 2025 financial results on Thursday, November 13, 2025, and will host a conference call and webcast at 4:30 PM ET. The webcast will feature an overview of the quarter from Jason Matuszewski, CEO, and…

You can read the full content here